Answers are grounded in this paper and cite their sources.
Neuroendocrine bladder cancer (NEBC) poses a formidable clinical challenge and attracts keen interests to explore immunotherapy as a viable treatment option. However, a comprehensive immunogenomic landscape has yet to be thoroughly investigated.
No takes yet. Share an insight, caveat, or question.
Zang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: